ACADIA Pharmaceuticals, Inc. (ACAD)
29.63
+0.13
(+0.44%)
USD |
NASDAQ |
Aug 24, 16:00
29.63
0.00 (0.00%)
After-Hours: 19:56
ACADIA Pharmaceuticals Shareholders Equity (Quarterly) : 1.307B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.307B |
| March 31, 2026 | 1.248B |
| December 31, 2025 | 1.227B |
| September 30, 2025 | 917.27M |
| June 30, 2025 | 822.38M |
| March 31, 2025 | 765.24M |
| December 31, 2024 | 732.79M |
| September 30, 2024 | 577.18M |
| June 30, 2024 | 516.70M |
| March 31, 2024 | 464.04M |
| December 31, 2023 | 431.76M |
| September 30, 2023 | 362.17M |
| June 30, 2023 | 395.79M |
| March 31, 2023 | 374.26M |
| December 31, 2022 | 400.41M |
| September 30, 2022 | 425.69M |
| June 30, 2022 | 434.85M |
| March 31, 2022 | 444.80M |
| December 31, 2021 | 540.89M |
| September 30, 2021 | 566.96M |
| June 30, 2021 | 564.84M |
| March 31, 2021 | 581.61M |
| December 31, 2020 | 627.01M |
| September 30, 2020 | 654.87M |
| June 30, 2020 | 663.01M |
| Date | Value |
|---|---|
| March 31, 2020 | 638.38M |
| December 31, 2019 | 699.14M |
| September 30, 2019 | 689.29M |
| June 30, 2019 | 388.91M |
| March 31, 2019 | 418.36M |
| December 31, 2018 | 479.08M |
| September 30, 2018 | 223.44M |
| June 30, 2018 | 264.72M |
| March 31, 2018 | 304.17M |
| December 31, 2017 | 335.28M |
| September 30, 2017 | 377.33M |
| June 30, 2017 | 415.14M |
| March 31, 2017 | 457.52M |
| December 31, 2016 | 518.41M |
| September 30, 2016 | 578.06M |
| June 30, 2016 | 408.82M |
| March 31, 2016 | 445.25M |
| December 31, 2015 | 199.76M |
| September 30, 2015 | 227.35M |
| June 30, 2015 | 255.82M |
| March 31, 2015 | 285.09M |
| December 31, 2014 | 309.49M |
| September 30, 2014 | 330.49M |
| June 30, 2014 | 350.11M |
| March 31, 2014 | 365.46M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Incyte Corp. | 6.344B |
| Agios Pharmaceuticals, Inc. | 1.026B |
| Biogen, Inc. | 18.85B |
| Insmed, Inc. | 757.49M |
| Vertex Pharmaceuticals, Inc. | 20.25B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.743B |
| Total Liabilities (Quarterly) | 436.29M |
| Debt to Equity Ratio | 0.0565 |
| Current Ratio | 3.388 |
| Net Debt Paydown Yield | -0.08% |